@FiercePharma: Saudi Arabia to review Avandia. Article | Follow @FiercePharma
> Perrigo Company, which develops, manufactures and distributes OTC and generic drugs, has signed a definitive merger agreement to acquire PBM Holdings, the leading store-brand infant formula manufacturer, for approximately $808 million in cash. Release
> Drugmaker Warner Chilcott, which bought Procter & Gamble Co.'s pharmaceuticals business last summer, will close its Mason facility by Aug. 31, eliminating 163 jobs. Story
> Patients with heart failure who have had a heart attack but not had artery-clearing angioplasty treatment are less likely to die early if they take Sanofi-Aventis and Bristol-Myers Squibb's drug Plavix, study data showed. Report
> Piramal Healthcare and Cipla Limited today announced the signing of a definitive agreement for purchase of all intellectual property rights in India related to i-pill, a leading emergency contraceptive brand for an aggregate consideration of Rs 95 crore. Release
> The U.S. Court of Appeals for the Federal Circuit has ruled in favor of Eli Lilly following an en banc rehearing last December. The rehearing concerned a 2007 judgment that held Lilly liable for infringement of four claims of U.S. Patent No. 6,410,516. The Federal Circuit held that the four patent claims are invalid due to inadequate written description. Release
> AMRI today announced that it and Sanofi-Aventis U.S. have filed a motion for a preliminary injunction in the United States District Court for the District of New Jersey seeking to enjoin Dr. Reddy's Laboratories from the commercial distribution of generic versions of Allegra-D 24 Hour ER-tablets in the U.S. Release
> German pharmaceutical company Merck KGaA expects to raise funds on the bond market on a regular basis, its chief financial officer said in a newspaper interview. Report
> APP Pharmaceuticals got the FDA nod for its generic version of Lundbeck's ductus arteriosus drug Indocin. Report
Biotech News
@FierceBiotech: Biovail founder Melnyk sells his remaining stake. Article | Follow @FierceBiotech
@JohnCFierce: CTIC shares have bounced back to 47 cents, down 48%. Where do they go from here? | Follow @JohnCFierce
> ChemGenex shares battered after FDA panel setback. Story
> Merck KGaA puts Stimuvax trial on hold after encephalitis strikes. Article
> Mark Leuchtenberger takes reins at Rib-X. Report
Manufacturing News
> Canada challenges Gates' HIV vaccine supply study. Item
> DHL doubles clinical trial logistics depots. Article
> A point-of-dispensing authentication system has been used in Belgium to improve influenza vaccination rates. Report
Biotech Research News
> Promising new drug target found for tuberculosis. Story
> Stem cells grow new trachea in child. Report
> A research team at Ohio State has successfully tested an experimental Type 2 diabetes therapy in mice. Article
And Finally... People who replace saturated fat in their diet with polyunsaturated fat reduce their risk of coronary heart disease by 19 percent, Harvard researchers found. Report